In which context is Beclin-1 a predictive biomarker according to the data?

• A. Universal biomarker for all MCTs
• B. Predictive value only in adjunctively treated tumors
• C. Predictive of recurrence in untreated tumors
• D. Not predictive in any context

Answer: (B)

Beclin-1 acts through autophagy, a process that can alter how tumor cells cope with stress from therapy. A predictive biomarker is one that forecasts how a tumor will respond to a specific treatment, not just the disease course in general. The data indicate that Beclin-1’s expression levels are associated with recurrence or treatment response only when tumors receive adjunctive therapy after the primary treatment. In untreated tumors, Beclin-1 does not reliably predict outcomes, and it does not serve as a universal biomarker for all MCTs.

So the favorable context is its predictive value specifically in tumors that are treated with adjunctive therapy.